Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines
Clinical and Experimental Dermatology, 11/10/09
Katoulis AC et al. – Undecylenoyl phenylalanine 2% is a novel depigmenting agent, which possibly acts as an alpha–melanocyte–stimulating hormone antagonist, thus inhibiting melaninogenesis. It achieved a significant lightening of the lesions with minimal side–effects. Most patients were satisfied with the improvement. Undecylenoyl phenylalanine 2% may represent a safe, effective and inexpensive therapeutic alternative for solar lentigines.
Related Articles
Long-term and recent recreational physical activity and survival after breast cancer: The California Teachers Study
Cancer Epidemiology, Biomarkers & Prevention, 10/26/09
Relevance Score: 47%
Intensity and timing of physical activity in relation to postmenopausal breast cancer risk: the prospective NIH-AARP Diet and Health Study
BMC Cancer, 10/05/09
Relevance Score: 47%
Gender and age-specific seasonal variations in physical activity among adults
Journal of Epidemiology and Community Health, 10/29/09
Relevance Score: 46%
Capillary Endothelial Na+, K+, ATPase Transporter Homeostasis and a New Theory for Migraine Pathophysiology
Headache: The Journal of Head and Face Pain, 10/27/09
Relevance Score: 46%
DNase1 activity in systemic lupus erythematosus patients with and without nephropathy
Rheumatology International, 10/26/09
Relevance Score: 46%
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy of a Single Educative Intervention in Patients with Chronic Plaque Psoriasis
Dermatology, 12/02/09
Efficacy and safety of long-term mycophenolate sodium therapy in pemphigus vulgaris
Journal of the European Academy of Dermatology and Venereology, 12/02/09
Different therapeutic modalities for treatment of melasma
Journal of Cosmetic Dermatology, 12/02/09
Sponsor
Article Search
Sponsor


See Latest Articles


